medigraphic.com
ISSN 1560-4381 (Impreso)

2022, Número 2

<< Anterior Siguiente >>

Correo Científico Médico 2022; 26 (2)


COVID-19 en embarazadas

Serrano GNB, Bermúdez GAJ, Fernández TM

Idioma: Español
Referencias bibliográficas: 38
Paginas:
Archivo PDF: 415.13 Kb.


RESUMEN

El embarazo aumenta el riesgo de la COVID-19 grave. Las gestantes infectadas por el SARS-CoV-2 presentan más complicaciones obstétricas y perinatales que las embarazadas no infectadas. Los objetivos de esta revisión bibliográfica fueron describir los cambios de la gestación que favorecen la infección por el SARS-CoV-2, las manifestaciones clínicas, complicaciones materno-fetales y el papel de la vacunación. Se buscó en: Google Académico (https://scholar.google.com.cu), PubMed Central (https://www.ncbi.nlm.nih.gov/pmc), SciELO (https://scielo.org/es) e Infomed (http://www.bvscuba.sld.cu/clasificacion-de-revista/revistas-cubanas) con los descriptores COVID-19, SARS-CoV-2 y embarazo/pregnancy. Dentro de las adaptaciones del embarazo que favorecen la infección están los trastornos de la inmunidad innata y adaptativa, los cambios en el sistema respiratorio y la respuesta de la coagulación. Las embarazadas presentan mayor riesgo de enfermedad grave y los síntomas principales de la COVID-19 son fiebre, tos, fatiga, disnea y pueden presentar complicaciones como aborto, cesáreas, parto pretérmino y preeclampsia. La vacunación anti-COVID-19 es un método preventivo eficaz.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Wang CL, Liu YY, Wu CH, Wang CY, Wang CH, Long CY. Impact of COVID-19 on Pregnancy. Int J Med Sci.2021[citado 09/11/2021]; 18(3): 763-767. Disponible en:https://doi.org/10.7150/ijms.49923

  2. WHO. WHO Coronavirus (COVID-19) Dashboard. Suiza,Ginebra:WHO;10/11/2021[citado 25/02/2022].Disponible en: https://covid19.who.int

  3. Razzaghi H, Meghani M, Pingali C, Crane B, Naleway A, Weintraub E, et al.COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 8, 2021. MMWR Morb Mortal Wkly Rep. 2021[citado 09/11/2021];70(24):895-899. Disponible en:https://www.cdc.gov/mmwr/volumes/70/wr/mm7024e2.htm

  4. Naves do Amaral W ,Leão de Moraes C, Dos Santos Rodrigues AP,Noll M,Tacon Arruda J, Carolina Rodrigues Mendonça C. Maternal Coronavirus Infections and Neonates Born to Mothers with SARS-CoV-2: A Systematic Review. Healthcare (Basel). 2020 [citado 09/11/2021];8(4):511. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712854/pdf/healthcare-08-00511.pdf

  5. Adhikari EH, Spong CY. COVID-19 Vaccination in Pregnant and Lactating Women. JAMA. 2021[citado 09/10/2021];325(11):1039-1040.Disponible en:https://jamanetwork.com/journals/jama/article-abstract/2776449

  6. Perdigón Portieles CJ, Hernández Toboso ML. Embarazo en tiempos de COVID-19, un acercamiento a la evidencia científica. Rev Cubana Obstet Ginecol. 2020[citado 09/11/2021];46(2). Disponible en:http://revginecobstetricia.sld.cu/index.php/gin/article/view/634

  7. 7.Di Mascio D , Buca D, Berghella V, Khalil A ,Rizzo G, Odibo A. Counseling in maternal-fetal medicine: SARS-CoV-2 infection in pregnancy. Ultrasound Obstet Gynecol. 2021[citado 09/11/2021];57(5):687-697. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251147/pdf/UOG-57-687.pdf

  8. Madjunkov M, Dviri M, Librach C. A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: a Canadian perspective. J Ovarian Res. 2020[citado 09/11/2021];13:140. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694590/

  9. Boushra MN, Koyfman A, Long B. COVID-19 in pregnancy and the puerperium: A review for emergency physicians. Am J Emerg Med. 2021[citado 09/11/2021]; 40: 193-198. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0735675720309517?via%3Dihub

  10. Mirbeyk M, Saghazadeh A, Rezaei N. A systematic review of pregnant women with COVID-19 and their neonates. Arch Gynecol Obstet. 2021 [citado 09/11/2021]: 304(1):5-38. Disponible en: https://link.springer.com/article/10.1007/s00404-021-06049-z

  11. Phoswa WN, Khaliq OP. Is pregnancy a risk factor of COVID-19? Eur J Obstet Gynecol Reprod Biol. 2020[citado 09/11/2021];252:605-609. Disponible en:https://www.sciencedirect.com/science/article/abs/pii/S0301211520304334?via%3Dihub

  12. Tolu LB, Ezeh A, Feyissa GT. Vertical transmission of Severe Acute Respiratory Syndrome Coronavirus 2: A scoping review. PLoS One.2021[citado 09/11/2021]; 16(4):0250196. Disponible en: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0250196

  13. Auriti C, De Rose DU, Mondì V, Stolfi I, Tzialla C. Neonatal SARS-CoV-2 Infection: Practical Tips. Pathogens. 2021 [citado 09/11/2021]; 10(5):611. Disponible en:https://doi.org/10.3390/pathogens10050611

  14. Vouga M, Favre G , Martinez Perez O , Pomar L , Forcen Acebal L, Abascal Saiz A, et al. Maternal outcomes and risk factors for COVID-19 severity among pregnant women. Sci Rep. 2021[citado 09/11/2021];11(1):13898. Disponible en:https://www.nature.com/articles/s41598-021-92357-y.pdf

  15. Wei SQ, Bilodeau Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ. 2021 [citado 09/11/2021];193(16):540-548.Disponible en:https://www.cmaj.ca/content/cmaj/193/16/E540.full.pdf

  16. Savirón Cornudella R, Villalba A, Esteban LM, Tajada M, Rodríguez Solanilla B, Andeyro Garcia M, et al. Screening of severe acute respiratory syndrome coronavirus-2 infection during labor and delivery using polymerase chain reaction and immunoglobulin testing. Life Sci. 2021[citado 09/11/2021]; 271: 119200. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871853/pdf/main.pdf

  17. Principi N, Esposito S. Is the Immunization of Pregnant Women against COVID-19 Justified?.Vaccines(Basel). 2021 [citado 09/11/2021];9(9):970. Disponible en:https://www.mdpi.com/2076-393X/9/9/970

  18. Male V. Are COVID-19 vaccines safe in pregnancy?. Nat Rev Immunol. 2021[citado 09/11/2021];21:200-201. Disponible en: https://doi.org/10.1038/s41577-021-00525-y

  19. Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol. 2020[citado 09/11/2021]; 222 (5): 415-426. Disponible en: https://doi.org/10.1016/j.ajog.2020.02.017

  20. Díaz Armas MT, Sánchez Artigas R, Matute Respo TZ, Llumiquinga Achi RA. Proteína de la espícula del virus SARS-CoV-2 y su relación con la enzima convertidora de angiotensina-2. Rev Inf Cient.2021 [citado 09/11/2021];100 (5) Disponible en:http://revinfcientifica.sld.cu/index.php/ric/article/view/3633

  21. Eckert A, Higgins D. CDC Public Health Imagen Library. Atlanta, Estados Unidos:Centers for Disease Control and Prevention;2020.Disponible en:https://phil.cdc.gov/Details.aspx?pid=23313

  22. Martins Vale AJ, Lopes Fernandes AC, Pierdoná Guzen F, Francisco Irochima Pinheiro F , Pereira de Azevedo E, Ney Cobucci R. Susceptibility to COVID-19 in Pregnancy, Labor, and Postpartum Period: Immune System, Vertical Transmission, and Breastfeeding. Front Glob Womens Health. 2021[citado 09/11/2021];2:602572. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593969/

  23. Mallah SI, Ghorab OK, Al-Salmi S, Abdellatif OS, Tharmaratnam T, Iskandar MA, et al. COVID-19: breaking down a global health crisis. Ann Clin Microbiol Antimicrob. 2021[citado 09/11/2021]; 20(1):35. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129964/pdf/12941_2021_Article_438.pdf

  24. 24.Chilamakuri R, Agarwal S. COVID-19: Characteristics andTherapeutics. Cells. 2021[citado 09/11/2021];10(2):206. Disponible en: https://www.mdpi.com/2073-4409/10/2/206

  25. Chen R, Zhang S, Su S, Ye H, Shu H. Interactions Between Specific Immune Status of Pregnant Women and SARS-CoV-2 Infection. Front Cell Infect Microbiol. 2021[citado 09/11/2021]; 11: 721309. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387674/pdf/fcimb-11-721309.pdf

  26. Wastnedge EAN, Reynolds RM, van Boeckel SR, Stock SJ, Denison FC, et al. Pregnancy and COVID-19. Physiol Rev. 2021[citado 09/11/2021]; 101: 303–318. Disponible en:https://journals.physiology.org/doi/pdf/10.1152/physrev.00024.2020

  27. Córdoba Vives S, Fonseca Peñaranda G. COVID-19 y Embarazo. Rev Med Costa Rica 2020[citado 09/11/2021];86(629):22-29. Disponible en:https://www.medigraphic.com/pdfs/revmedcoscen/rmc-2020/rmc20629f.pdf

  28. Ferrer Oliveras R, Mendoza M, Capote S, Pratcorona L, Esteve Valverde E, Cabero Roura L, et al. Immunological and physiopathological approach of COVID-19 in pregnancy. Arch Gynecol Obstet .2021[citado 09/11/2021];304(1):39-57. Disponible en:https://link.springer.com/article/10.1007/s00404-021-06061-3

  29. Miguel Soca P, Feria Díaz GE, González Benítez SN, Leyva Montero MA.Obesidad, inflamación y embarazo, una tríada peligrosa. Rev Cubana Obstet Ginecol.2021[citado 09/11/2021]; 46 (4) Disponible en:http://revginecobstetricia.sld.cu/index.php/gin/article/view/605

  30. González Villalva A, de la Peña Díaz A, Rojas Lemus M, López Valdez N, Ustarroz Cano M,García Peláez I,et al. Fisiología de la hemostasia y su alteración por la coagulopatía en COVID-19. Rev Fac Med. 2020[citado 09/11/2021];63(5):45-57. Disponible en:https://www.revistafacmed.com/index.php?option=com_phocadownload&view=file&id=1344:fisiologa-de-la-hemostasia-y-su-alteracin&Itemid=1

  31. Lokken EM, Taylor GG, Huebner EM,Jeroen Vanderhoeven,Hendrickson S, Coler B, et al. Higher severe acute respiratory syndrome corona-virus 2 infection rate in pregnant patients. Am J Obstet Gynecol.2021[citado 09/11/2021];225(1):75.e1-75.e16. Disponible en:https://doi.org/10.1016/j.ajog.2021.02.011

  32. Debelenko L, Katsyv I, Chong AM, Peruyero L, Szabolcs M, Uhlemann AC. Trophoblast damage with acute and chronic intervillositis: disruption of the placental barrier by severe acute respiratory syndrome coronavirus 2. Hum Pathol. 2021 [citado 09/11/2021]; 109: 69-79. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733682/pdf/main.pdf

  33. Papageorghiou AT, Deruelle P, Gunier RB, Rauch S, García-May PK, Mhatre M, et al. Preeclampsia and COVID-19: resultsfrom the INTERCOVID prospective longitudinal study. Am J Obstet Gynecol.2021[citado 09/11/2021];225(3):289.e1-289.e17. Disponible en:https://www.sciencedirect.com/science/article/abs/pii/S0002937821005615?via%3Dihub

  34. Conde Agudelo A, Romero R. SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis. Am J Obstet Gynecol.2022[citado 09/11/2021]:226(1):68-89.Disponible en:https://www.sciencedirect.com/science/article/abs/pii/S000293782100795X?via%3Dihub

  35. Luxi N, Giovanazzi A, Capuano A, Crisafulli S , Cutroneo PM,Pia Fantini M , et al. COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety. Drug Saf. 2021[citado 09/11/2021]:44(12):1247-1269.Disponible en:https://link.springer.com/article/10.1007/s40264-021-01131-6

  36. Garg, I, Shekhar R, Sheikh, AB, Pal S. COVID-19 Vaccine in Pregnant and LactatingWomen: A Review of Existing Evidence and Practice Guidelines. Infect Dis Rep.2021[citado 09/11/2021];13(3):685-699. Disponible en: https://doi.org/10.3390/idr13030064

  37. Stafford IA, Parchem JG, Sibai BM. The coronavirus disease 2019 vaccine in pregnancy: risks, benefits, and recommendations. Am J Obstet Gynecol. 2021 [citado 09/11/2021]; 224(5): 484-495. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847190/pdf/main.pdf

  38. Kharbanda EO, Haapala J, DeSilva M, Vazquez Benitez G, Vesco KK, Naleway AL, et al. Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy. JAMA. 2021[citado04/11/2021];326(16):1629-1631. Disponible en:https://jamanetwork.com/journals/jama/fullarticle/2784193




2020     |     www.medigraphic.com